CD163 and breast carcinoma: Previous studies have demonstrated that CD163+ macrophages in the tumour stroma of breast cancer tissues correlated to high tumour grade, larger tumour size, triple negative cancers, and suggest that CD68+ macrophages in the tumour stroma is an independent prognostic marker for cancer free survival [56,57].